Filter by:

Date
Business
17th November 2023

Semarion One of the Killer50 Life Sciences Companies

The continues upsurge in excellence throughout the Science & Technology segment in the Cambridge Cluster and its hinterland has prompted a decision to create Killer50 lists for each of the Life Sciences and Hi-Tech segme...
Read more
Events
31st October 2023

WEBINAR: SemaCyte Microcarriers - Move & Freeze Adherent Cells to Accelerate Your Assays

Semarion will explain how their unique SemaCyte® microcarriers function and accelerate a variety of cell based assays. We have recently launched an Early Adopter Programme which offers free and discounted materials alon...
Read more
Partnering
18th October 2023

Semarion announces Early Adopter Programme for SemaCyte Microcarrier Platform to Accelerate Cell Assays

SemaCyte Microcarrier Platform addresses limitations within adherent cell assays to accelerate the pace of in vitro drug discovery. Early access will further validate the technology and provide feedback on applicability ...
Read more
Business
17th September 2023

Semarion Receives Pathfinder Award for Influencing Nextgen Life Sciences Innovations

Business Weekly and Bruntwood SciTech handed the 2023 pathfinder award to Semarion, in recognition of their SemaCyte microcarrier platform as a the best nextgen life sciences solutions....
Read more
Business
25th June 2023

Semarion Featured on Cambridge University's Innovation & Entrepreneurship Platform

IE Cambridge interviewed Semarion's CEO, Jeroen, and made a 2-min feature video about the innovation and entrepreneurial journey behind the company....
Read more
Events
15th June 2023

Semarion Top 5 Most Exciting Emerging Solutions at Future Lab Live 2023

Semarion had a booth among ~100 other exciting early-stage companies who were presenmting their innovative solutions for the lab of tomorrow. After two pitching sessions, Semarion (accelerating adherent cell assays) got ...
Read more
Events
1st June 2023

Interview & Highlights of the BIA Start-Up Festival

During this year's BIA Start-Up Festival 2023 (25 May), Semarion's CEO joined the panel on "Experiences of founding entrepreneurs" and spoke with the BIA during a video interview about why we need more investment in the ...
Read more
Technology
28th December 2022

Pine Trees Dancing to the Rhythm of Magnets

We made SemaCyte microcarriers in the shape of pine trees and loaded them with A549 lung carcinoma cells. After their release, we moved them around with an external magnetic field and dispensed them for an IC50 dose resp...
Read more
Business
4th November 2022

Business Weekly - Investments in impulse’s ‘super entrepreneurs’ top £100m

Semarion is listed as one of the alumni of Cambridge University’s successful entrepreneurship and intrapreneurship programme – impulse – which have attracted more than £100 million in funding and investments over ...
Read more
Events
10th June 2022

Semarion Joins Panel on "Shaping the future of interdisciplinary interactions"

This symposium is an opportunity for scientists from academia and industry to discuss the latest academic and pre-clinical research and how it could be applied in the pharma and biotech industry to develop new treatments...
Read more
Events
15th May 2022

Discussing Semarion at Connect Health Tech (Podcast)

In this special two-guest episodes of  Health Tech's Joining the Dots podcast, Paula Rogers-Brown explores the theme of taking research from idea to proof of concept and beyond, with Dr Jason Mellad, Co-Founder and C...
Read more
Events
16th March 2022

Semarion Highlighted in the Advanced Therapies Start-Up Report

Advanced Therapies 2022 will showcase the "100 hottest, most interesting advanced therapy medicinal products (ATMP) start-ups". Semarion is excited to be part that! While we our SemaCyte® technology is not a therapeutic...
Read more
Business
4th March 2022

Semarion CEO to be listed as #21toWatch Top21.2022

Our CEO, Jeroen Verheyen, was listed as #21toWatch Top21.2022 by Cofinitive, alongside other great people, companies, and 'things'....
Read more
Technology
28th February 2022

Biopharma Reporter - Startup looking to create paradigm shift in cell screening

While assays with suspension cells have benefitted from lots of innovative solutions, such as those using cytometry or microfluids, there has been a lack of innovation for adherent cell assays. The anchorage dependance l...
Read more
Business
22nd February 2022

Semarion raises £2.14m seed funding to commercialise cell assaying platform

Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodolo...
Read more
Events
15th November 2021

Semarion to present as one of the Rising Biotech Stars at Genesis 2021

We are pleased to announce that we will be presenting at the Genesis 2021 conference organised by One Nucleus. Our CEO, Jeroen Verheyen, will summarise what Semarion is building at the Rising Biotech Stars. This content ...
Read more
Partnering
27th July 2021

University Enterprise Zone - Semarion as case study for Connect Health Tech

As a spin-out company from the University of Cambridge, Semarion and its co-founders, Jeroen & Tarun, have gained support from a variety of networks, such as the NanoDTC, the Cambridge CRUK Early Detection Programme, the...
Read more
Events
10th September 2020

Semarion receives runner up prize for the "Pitch and Partner Panel" at the Advanced Therapies Congress & Expo 2020

Advanced Therapies is Europe’s most important advanced therapies conference and exhibition. Semarion is excited to have received the runner up prize for the startup pitch it delivered at the "Pitch and Partner Panel" s...
Read more
Events
7th July 2020

Semarion presents at On Helix 2020

Semarion is excited about attending On Helix 2020. Connect with our CEO Jeroen Verheyen or CTO Tarun Vemulkar if you are there. Jeroen will and speaking during the "Rising Biotech Stars" session (13 July 16.30 BST) about...
Read more
Events
1st July 2020

Semarion to speak at the "Life Science Entrepreneurs + Accelerators Digital Meetup"

Are you an entrepreneur or a potential entrepreneur thinking about starting a company? Join accelerators, founders and ecosystem builders for this digital meetup for entrepreneurs to celebrate our startup ecosystem! Sema...
Read more
Events
23rd June 2020

Semarion Pitches at the Milner Therapeutics Symposium 2020

Semarion will join the Milner Therapeutics Symposium 2020 on June 26th to speak about revolutionizing cell-based assays using SemaCyte microcarriers. We will be pitching alongside other Cambridge-based biotech startups. ...
Read more
Business
22nd June 2020

Semarion to join the Start Codon programme and receive £250k pre-seed investment

Start Codon, a new model of life science and healthcare business accelerator, today proudly debuts its first cohort of start-up companies. Start Codon aims to minimise risk and translate early stage research into success...
Read more